SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rebekah Carney, Jack Cotter, Tim Bradshaw, Joseph Firth, Alison R. Yung, Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis, Schizophrenia Research, 2016, 170, 2-3, 290

    CrossRef

  2. 2
    A. M. Auther, K. S. Cadenhead, R. E. Carrión, J. Addington, C. E. Bearden, T. D. Cannon, T. H. McGlashan, D. O. Perkins, L. Seidman, M. Tsuang, E. F. Walker, S. W. Woods, B. A. Cornblatt, Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample, Acta Psychiatrica Scandinavica, 2015, 132, 1
  3. 3
    I. Zorrilla, J. Aguado, J. M. Haro, S. Barbeito, S. López Zurbano, A. Ortiz, P. López, A. Gonzalez-Pinto, Cannabis and bipolar disorder: does quitting cannabis use during manic/mixed episode improve clinical/functional outcomes?, Acta Psychiatrica Scandinavica, 2015, 131, 2
  4. 4
    T. Kraan, E. Velthorst, L. Koenders, K. Zwaart, H. K. Ising, D. van den Berg, L. de Haan, M. van der Gaag, Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis, Psychological Medicine, 2015, 1

    CrossRef

  5. 5
    W. R. Kates, N. Russo, W. M. Wood, K. M. Antshel, S. V. Faraone, W. P. Fremont, Neurocognitive and familial moderators of psychiatric risk in velocardiofacial (22q11.2 deletion) syndrome: a longitudinal study, Psychological Medicine, 2015, 45, 08, 1629

    CrossRef

  6. 6
    Susana Fernández-Mondragón, Ana Adan, Personality in male patients with substance use disorder and/or severe mental illness, Psychiatry Research, 2015, 228, 3, 488

    CrossRef

  7. 7
    L. Buchy, K. S. Cadenhead, T. D. Cannon, B. A. Cornblatt, T. H. McGlashan, D. O. Perkins, L. J. Seidman, M. T. Tsuang, E. F. Walker, S. W. Woods, R. Heinssen, C. E. Bearden, D. Mathalon, J. Addington, Substance use in individuals at clinical high risk of psychosis, Psychological Medicine, 2015, 45, 11, 2275

    CrossRef

  8. 8
    Guillermo A. Castaño Pérez, Gloria Maria Sierra Hincapié, Trastorno dual en población general de Itagüí, Colombia, Revista Colombiana de Psiquiatría, 2015,

    CrossRef

  9. 9
    L. Clausen, C. R. Hjorthøj, A. Thorup, P. Jeppesen, L. Petersen, M. Bertelsen, M. Nordentoft, Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial, Psychological Medicine, 2014, 44, 01, 117

    CrossRef

  10. 10
    Frauke Schultze-Lutter, Benno G. Schimmelmann, Early Detection and Treatment of Psychosis: The Bern Child and Adolescent Psychiatric Perspective, Advances in Psychiatry, 2014, 2014, 1

    CrossRef

  11. 11
    T. Lataster, K. Verweij, W. Viechtbauer, Effect of illness expression and liability on familial associations of clinical and subclinical psychosis phenotypes, Acta Psychiatrica Scandinavica, 2014, 129, 1
  12. 12
    Samuel T. Wilkinson, Rajiv Radhakrishnan, Deepak Cyril D’Souza, Impact of Cannabis Use on the Development of Psychotic Disorders, Current Addiction Reports, 2014, 1, 2, 115

    CrossRef

  13. 13
    Kelly P. Owen, Mark E. Sutter, Timothy E. Albertson, Marijuana: Respiratory Tract Effects, Clinical Reviews in Allergy & Immunology, 2014, 46, 1, 65

    CrossRef

  14. 14
    Mei-Hua Hall, Deborah L. Levy, Dean F. Salisbury, Steve Haddad, Patience Gallagher, Mary Lohan, Bruce Cohen, Dost Öngür, Jordan W. Smoller, Neurophysiologic effect of GWAS derived schizophrenia and bipolar risk variants, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2014, 165, 1
  15. 15
    S. Alemany, B. Arias, M. Fatjó-Vilas, H. Villa, J. Moya, M. I. Ibáñez, G. Ortet, C. Gastó, L. Fañanás, Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes, Acta Psychiatrica Scandinavica, 2014, 129, 1
  16. 16
    Jean Addington, Nevicia Case, Majid M. Saleem, Andrea M. Auther, Barbara A. Cornblatt, Kristin S. Cadenhead, Substance use in clinical high risk for psychosis: a review of the literature, Early Intervention in Psychiatry, 2014, 8, 2
  17. 17
    Debra A Russo, Jan Stochl, Michelle Painter, Peter B Jones, Jesus Perez, Substance use in people at clinical high-risk for psychosis, BMC Psychiatry, 2014, 14, 1

    CrossRef

  18. 18
    Nikos C. Stefanis, Milan Dragovic, Brian D. Power, Assen Jablensky, David Castle, Vera A. Morgan, The effect of drug use on the age at onset of psychotic disorders in an Australian cohort, Schizophrenia Research, 2014, 156, 2-3, 211

    CrossRef

  19. You have free access to this content19
    Duccio Papanti, Fabrizio Schifano, Giulia Botteon, Francesca Bertossi, Jason Mannix, Daniela Vidoni, Matteo Impagnatiello, Elisabetta Pascolo-Fabrici, Tommaso Bonavigo, “Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report, Human Psychopharmacology: Clinical and Experimental, 2013, 28, 4
  20. 20
    Angelo Giovanni Icro Maremmani, Luca Rovai, Fabio Rugani, Silvia Bacciardi, Matteo Pacini, Liliana Dell'Osso, Icro Maremmani, Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report, Case Reports in Psychiatry, 2013, 2013, 1

    CrossRef

  21. 21
    R.K.R. Salokangas, P. Dingemans, M. Heinimaa, T. Svirskis, S. Luutonen, J. Hietala, S. Ruhrmann, G. Juckel, H. Graf von Reventlow, D. Linszen, M. Birchwood, P. Patterson, F. Schultze-Lutter, J. Klosterkötter, Prediction of psychosis in clinical high-risk patients by the Schizotypal Personality Questionnaire. Results of the EPOS project, European Psychiatry, 2013, 28, 8, 469

    CrossRef

  22. 22
    Jacqueline Stowkowy, Jean Addington, Predictors of a clinical high risk status among individuals with a family history of psychosis, Schizophrenia Research, 2013, 147, 2-3, 281

    CrossRef

  23. 23
    F. Smeets, T. Lataster, R. van Winkel, R. de Graaf, M. ten Have, J. van Os, Testing the hypothesis that psychotic illness begins when subthreshold hallucinations combine with delusional ideation, Acta Psychiatrica Scandinavica, 2013, 127, 1
  24. 24
    Anthony James, Christine James, Thomas Thwaites, The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review, Psychiatry Research: Neuroimaging, 2013, 214, 3, 181

    CrossRef

  25. 25
    D. H. Nieman, E. Velthorst, H. E. Becker, L. de Haan, P. M. Dingemans, D. H. Linszen, M. Birchwood, P. Patterson, R. K. R. Salokangas, M. Heinimaa, A. Heinz, G. Juckel, H. G. von Reventlow, A. Morrison, F. Schultze-Lutter, J. Klosterkötter, S. Ruhrmann, The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis, Acta Psychiatrica Scandinavica, 2013, 127, 1
  26. 26
    R. J. M. Niesink, M.W. van Laar, Cannabidiol: de nieuwe haarlemmerolie of een hype?, Verslaving, 2012, 8, 2, 63

    CrossRef

  27. 27
    Sibel Algon, James Yi, Monica E. Calkins, Christian Kohler, Karin E. Borgmann-Winter, Evaluation and Treatment of Children and Adolescents With Psychotic Symptoms, Current Psychiatry Reports, 2012, 14, 2, 101

    CrossRef

  28. 28
    Wilfrid Noel Raby, John J. Mariani, Frances R. Levin, Edward V. Nunes, Pharmacological Treatment of Substance Abuse Disorders,